Abstract:Objective: To investigate the maternal and fetal outcomes of expectant treatment and early termination of pregnancy in pregnant women with suspected invasive placenta accreta spectrum disorders (PAS) in the second trimester. Methods: A retrospective cohort study was performed on 51 pregnant women with suspected invasive PAS (ultrasound score ≥10) evaluated by ultrasound with gestational age <26 weeks and confirmed as invasive PAS by intraoperative findings or postoperative pathology in Peking University Third Hospital from January 2015 to January 2022. According to the informed choice of pregnant women and their families, they were divided into expectant treatment group (37 cases) and mid-term termination group (14 cases). The general clinical data and outcome indexes of the two groups were analyzed by χ2 test, Mann-Whitney U rank sum test, logistic regression and linear regression. Results: (1) General clinical data: among 51 pregnant women who were assessed as suspected invasive PAS by ultrasonography in the second trimester, invasive PAS was finally diagnosed by intraoperative findings and postoperative pathology, among which 46 cases (90%) were placenta percreta and 5 cases (10%) were placenta increta. (2) Outcome indicators: univariate analysis showed that there were no statistically significant differences in the intraoperative blood loss (median: 2 200 vs 2 150 ml), the proportion of blood loss >1 500 ml [73% (27/37) vs 9/14], the hysterectomy rate [62% (23/37) vs 8/14], the rate of intensive care unit (ICU) admission [78% (29/37) vs 9/14] between the expectant treatment group and the mid-term termination group (all P>0.05). Multivariate analysis showed that the rate of intraoperative blood loss >1 500 ml (aOR=0.481, 95%CI: 0.017-13.958; P=0.670), hysterectomy (aOR=0.264, 95%CI: 0.011-6.569, P=0.417) and ICU admission (aOR=1.327, 95%CI: 0.048-36.882, P=0.867) between the two groups showed no statistical differences. (3) Outcome analysis: all 37 cases in the expectant treatment group had live births and no early neonatal death. Five pregnant women (14%, 5/37) in the expectant treatment group underwent emergency cesarean section in the course of expectant treatment. In the mid-term termination group, all pregnancies were terminated by operation, including 9 cases of hysterectomy and 5 cases of placental hysterectomy. There was 1 fetal survival (gestational age of termination: 27+4 weeks) and 13 fetal death in the mid-term termination group. Conclusions: Pregnant women who are diagnosed as suspected invasive PAS, especially those with placenta percreta, have the risk of uterine rupture and emergency surgery in the course of expectant treatment. However, early termination of pregnancy does not reduce the risk of intraoperative blood loss and hysterectomy.

Clinical analysis of second-trimester pregnancy termination after previous caesarean delivery in 51 patients with placenta previa and placenta accreta spectrum: a retrospective study

Effects of Prophylactic Uterine Artery Embolization on Second-Trimester Induced Abortions in Patients with Placenta Previa

Prophylactic Uterine Artery Embolization in Second-Trimester Pregnancy Termination with Complete Placenta Previa

Using a Cervical Ripening Balloon to Penetrate the Placenta and Quickly Reduce Bleeding by Pressing Against the Placenta During Pregnancy Termination for Patients with Placenta Previa in the Second Trimester

[Outcome Analysis of Pregnancy Termination and Expectant Treatment in Pregnant Women with Suspected Invasive Placenta Accreta Spectrum Disorders in the Second Trimester].

Clinical analysis of prophylactic uterine artery embolization combined with double balloon catheter for second-trimester pregnancy termination in cases of complete placenta previa: A retrospective study

Termination of a Second-Trimester Pregnancy with Placenta Accreta Spectrum Disorder

Different Methods for Termination of Mid-trimester Pregnancy With Placenta Previa

Research Progresses of Second-Trimester Pregnancy Termination in Pregnant Women with Placenta Previa Status

The Method for Termination of Mid-Trimester Pregnancy with Placenta Previa: A Case Study

Subsequent Placenta Accreta after Previous Mifepristone-Induced Abortion: A Case Report.

A Retrospective Study on the Clinical Effect of Uterine Artery Embolization Combined with Cervical Double Balloon for Patients with Complete Placenta Previa Undergoing Pregnancy Termination in the Second Trimester

Clinical analysis of uterine artery embolization combined with double balloon catheter plus curettage for patients with placenta previa who underwent pregnancy termination and suffered antenatal massive hemorrhage in the 2nd trimester: Three case reports.

Clinical analysis of termination of mid -term pregnancy combined with complete placenta previa

Clinical factors associated with subsequent surgical intervention in women undergoing early medical termination of viable or non-viable pregnancies

Maternal outcomes of conservative management and cesarean hysterectomy for placenta accreta spectrum disorders: a systematic review and meta-analysis

731: the Risk of Abnormal Placentation and Hemorrhage in Subsequent Pregnancy Following Primary Elective Caesarean Delivery

Conservative stepwise surgical approach for management of placenta previa accreta: A prospective case series study

Effects of Different Modes of Anesthesia on Maternal and Neonatal Outcomes in Puerperas with Placenta Previa and Accreta Undergoing Cesarean Section for Second Birth

The application of prophylactic balloon occlusion of the internal iliac artery for the treatment of placenta accreta spectrum with placenta previa: a retrospective case-control study

Successful conservative surgical management of first-trimester placenta accreta: Case report